Defining Nonadherence and Nonpersistence to Anti-Vascular Endothelial Growth Factor Therapies in Neovascular Age-Related Macular Degeneration

Okada, Mali; Wong, Tien; Mitchell, Paul; Eldem, Bora; Talks, S.; Aslam, Tariq; Daien, Vincent; Rodriguez, Francisco; Gale, Richard; Barratt, Jane; Finger, Robert; Loewenstein, Anat

doi:10.1001/jamaophthalmol.2021.1660

Defining Nonadherence and Nonpersistence to Anti-Vascular Endothelial Growth Factor Therapies in Neovascular Age-Related Macular Degeneration

Okada M., Wong T. Y., Mitchell P., Eldem B., Talks S. J., Aslam T., ...Daha Fazla

JAMA OPHTHALMOLOGY, cilt.139, ss.769-776, 2021 (SCI-Expanded, Scopus)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 139
Basım Tarihi: 2021
Doi Numarası: 10.1001/jamaophthalmol.2021.1660
Dergi Adı: JAMA OPHTHALMOLOGY
Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, BIOSIS, CAB Abstracts, CINAHL, EMBASE, MEDLINE, Veterinary Science Database
Sayfa Sayıları: ss.769-776
Açık Arşiv Koleksiyonu: AVESİS Açık Erişim Koleksiyonu
Hacettepe Üniversitesi Adresli: Evet

Özet

IMPORTANCE Poor adherence or persistence to treatment can be a barrier to optimizing clinical practice (real-world) outcomes to intravitreal injection therapy in patients with neovascular age-related macular degeneration (nAMD). Currently, there is a lack of consensus on the definition and classification of adherence specific to this context.